AEye Rises 17% on Strategic Smart City Partnership with Blue Band LLC
AEye, Inc. (LIDR) gained 17.17% to lead the PRISM Emerging EV Index after announcing a strategic partnership with Blue-Band LLC to advance smart city infrastructure. The collaboration integrates AEye’s Apollo lidar technology with Blue-Band’s AI-powered Integrator-AI™ platform, creating next-generation traffic systems under the OPTIS™ initiative. The partnership aims to enhance traffic monitoring, incident detection, and real-time urban mobility solutions, with management highlighting the potential to reduce congestion and improve public safety at intersections.
PDS Biotech Climbs 16% on Strong Phase 2 Survival Data in Head and Neck Cancer
PDS Biotechnology Corporation (PDSB) rose 15.97%, boosting the PRISM Emerging Women’s Health Index, after releasing final topline results from its VERSATILE-002 Phase 2 trial. Patients treated with its HPV16-targeted immunotherapy PDS0101 in combination with Keytruda® demonstrated a median overall survival (mOS) of 39.3 months in HPV16-positive head and neck cancer, more than double standard outcomes with Keytruda alone (17.9 months). Management emphasized the durability of survival outcomes and the ongoing pivotal VERSATILE-003 Phase 3 trial as positioning the company for leadership in HPV-driven cancers.
Other PRISM Mid-Day Movers:
- ESSA Pharma Inc. (EPIX) fell 59.45%
- FiscalNote Holdings Inc. (NOTE) declined 16.66%
- Tilray Brands, Inc. (TLRY) gained 15.57%
The post PRISM Mid-Day Movers: Smart Mobility Partnerships and Breakthrough Cancer Data appeared first on PRISM MarketView.
